(MTS) ArcelorMittal - Overview
Stock: Steel, Iron-Ore, Coking-Coal
| Risk 5d forecast | |
|---|---|
| Volatility | 40.0% |
| Relative Tail Risk | -14.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.99 |
| Alpha | 95.00 |
| Character TTM | |
|---|---|
| Beta | 0.495 |
| Beta Downside | 0.745 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.97% |
| CAGR/Max DD | 0.82 |
EPS (Earnings per Share)
Revenue
Description: MTS ArcelorMittal February 18, 2026
ArcelorMittal S.A. (ticker MTS) is a globally integrated steel and mining group headquartered in Luxembourg. Through its subsidiaries it produces a full spectrum of steel products-from semi-finished slabs and billets to finished flat and long items such as hot-rolled coils, tinplate, structural sections, and seamless pipes-as well as mining outputs including iron-ore concentrates and coking coal. Its customer base spans automotive, appliance, engineering, construction, energy, and machinery sectors, and it markets these goods via a centralized sales organization and a network of distributors.
Key recent data (as of Q4 2024):
• FY 2023 revenue reached €79 billion, up 5 % YoY, driven by higher steel prices and a modest rebound in automotive demand (source: ArcelorMittal annual report).
• EBITDA margin improved to 12.8 % from 11.4 % in 2022, reflecting better capacity utilization (≈78 % vs 71 % in 2022) and cost-saving initiatives.
• Net debt stood at €31 billion, giving a net-debt-to-EBITDA ratio of ~2.4×, which remains elevated but below the 3.0× threshold historically associated with heightened credit risk for the sector.
• Macro drivers: Global steel demand is projected to grow 2.5 % in 2025, with infrastructure spending in emerging markets and a shift toward higher-value coated products underpinning the outlook (World Steel Association).
• Commodity exposure: Iron-ore prices have averaged $115/ton in 2024, a 15 % increase from 2023, supporting mining revenue but also pressuring input costs.
If you want a data-rich, quantitative deep-dive into ArcelorMittal’s valuation and risk profile, consider exploring the ValueRay platform for additional analytics.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 3.28b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.05 > 1.0 |
| NWC/Revenue: 12.66% < 20% (prev 12.10%; Δ 0.56% < -1%) |
| CFO/TA 0.04 > 3% & CFO 4.28b > Net Income 3.28b |
| Net Debt (7.93b) to EBITDA (6.46b): 1.23 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (766.0m) vs 12m ago -0.78% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 68.26% > 50% (prev 69.86%; Δ -1.60% > 0%) |
| Interest Coverage Ratio: 11.02 > 6 (EBITDA TTM 6.46b / Interest Expense TTM 308.1m) |
Altman Z''
| A: 0.08 (Total Current Assets 30.61b - Total Current Liabilities 22.52b) / Total Assets 97.71b |
| B: error (Retained Earnings missing) |
| C: 0.04 (EBIT TTM 3.40b / Avg Total Assets 93.55b) |
| D: 1.32 (Book Value of Equity 54.47b / Total Liabilities 41.17b) |
Beneish M -4.00
| DSRI: 0.60 (Receivables 3.48b/5.66b, Revenue 63.85b/62.44b) |
| GMI: 0.09 (GM 100.0% / 9.27%) |
| AQI: 0.89 (AQ_t 0.27 / AQ_t-1 0.30) |
| SGI: 1.02 (Revenue 63.85b / 62.44b) |
| TATA: -0.01 (NI 3.28b - CFO 4.28b) / TA 97.71b) |
| Beneish M-Score: -4.23 (Cap -4..+1) = AAA |
What is the price of MTS shares?
Over the past week, the price has changed by +1.94%, over one month by +29.24%, over three months by +57.02% and over the past year by +96.97%.
Is MTS a buy, sell or hold?
What are the forecasts/targets for the MTS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 52 | -3.1% |
| Analysts Target Price | - | - |
MTS Fundamental Data Overview February 18, 2026
P/E Trailing = 15.4582
P/E Forward = 14.7275
P/S = 0.6654
P/B = 0.8832
P/EG = 0.6556
Revenue TTM = 63.85b EUR
EBIT TTM = 3.40b EUR
EBITDA TTM = 6.46b EUR
Long Term Debt = 10.49b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 2.74b EUR (from shortTermDebt, last fiscal year)
Debt = 13.41b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 7.93b EUR (from netDebt column, last fiscal year)
Enterprise Value = 48.76b EUR (40.83b + Debt 13.41b - CCE 5.48b)
Interest Coverage Ratio = 11.02 (Ebit TTM 3.40b / Interest Expense TTM 308.1m)
EV/FCF = 840.7x (Enterprise Value 48.76b / FCF TTM 58.0m)
FCF Yield = 0.12% (FCF TTM 58.0m / Enterprise Value 48.76b)
FCF Margin = 0.09% (FCF TTM 58.0m / Revenue TTM 63.85b)
Net Margin = 5.14% (Net Income TTM 3.28b / Revenue TTM 63.85b)
Gross Margin = unknown ((Revenue TTM 63.85b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.50 (Enterprise Value 48.76b / Total Assets 97.71b)
Interest Expense / Debt = 1.31% (Interest Expense 176.1m / Debt 13.41b)
Taxrate = 9.97% (373.6m / 3.75b)
NOPAT = 3.06b (EBIT 3.40b * (1 - 9.97%))
Current Ratio = 1.36 (Total Current Assets 30.61b / Total Current Liabilities 22.52b)
Debt / Equity = 0.25 (Debt 13.41b / totalStockholderEquity, last fiscal year 54.47b)
Debt / EBITDA = 1.23 (Net Debt 7.93b / EBITDA 6.46b)
Debt / FCF = 136.8 (Net Debt 7.93b / FCF TTM 58.0m)
Total Stockholder Equity = 52.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 3.28b / Total Assets 97.71b)
RoE = 6.27% (Net Income TTM 3.28b / Total Stockholder Equity 52.35b)
RoCE = 5.40% (EBIT 3.40b / Capital Employed (Equity 52.35b + L.T.Debt 10.49b))
RoIC = 4.59% (NOPAT 3.06b / Invested Capital 66.55b)
WACC = 6.12% (E(40.83b)/V(54.24b) * Re(7.74%) + D(13.41b)/V(54.24b) * Rd(1.31%) * (1-Tc(0.10)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.93%
[DCF Debug] Terminal Value 79.63% ; FCFF base≈430.8m ; Y1≈282.8m ; Y5≈129.0m
Fair Price DCF = N/A (negative equity: EV 3.85b - Net Debt 7.93b = -4.08b; debt exceeds intrinsic value)
EPS Correlation: -68.70 | EPS CAGR: -40.19% | SUE: 0.09 | # QB: 0
Revenue Correlation: -72.91 | Revenue CAGR: -5.77% | SUE: 3.48 | # QB: 1
EPS current Year (2026-12-31): EPS=3.94 | Chg30d=-0.143 | Revisions Net=-2 | Growth EPS=+20.6% | Growth Revenue=+9.3%
EPS next Year (2027-12-31): EPS=4.68 | Chg30d=+0.095 | Revisions Net=-1 | Growth EPS=+19.0% | Growth Revenue=+4.3%